Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells. ... Read ...

Another antibody drug conjugate disitamab vedotin (an anti-HER2 antibody drug conjugate with MMAE payload) has also been shown to potentially pair well with immunotherapy. Disitamab vedotin + ...

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

However, some nerve fibers remained active and continued promoting cancer growth. To completely cut off nerve support, the ...

Aldrich, 61, has also played with the likes of Lion, Hurricane, House of Lords, Bad Moon Rising and Revolution Saints. Also, ...

China has become the second-largest developer of new drugs, behind only America. Read more at straitstimes.com.

Professor Georgina Long from the Melanoma Institute Australia said of 36 terminal patients given the combination therapy, ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...